11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
artículo científico publicado en 2010
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
artículo científico publicado en 2017
1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France
article
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
artículo científico publicado en 2017
37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden
artículo científico publicado en 2015
A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older
artículo científico publicado en 2018
A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden
artículo científico publicado en 2015
A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease
artículo científico publicado en 2016
A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease
scientific article published on 05 December 2018
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
artículo científico publicado en 2017
A Practical Guide to Immunoassay Method Validation
artículo científico publicado en 2015
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
artículo científico publicado en 2017
A Season of American Football Is Not Associated with Changes in Plasma Tau.
artículo científico publicado en 2017
A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury
scientific article published on 19 June 2019
A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity
artículo científico publicado en 2004
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia
artículo científico publicado en 2016
A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease
scientific article published on 23 February 2019
A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
artículo científico publicado en 2008
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease
artículo científico publicado en 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
scientific article published on 18 December 2019
A multi-center study of neurofilament assay reliability and inter-laboratory variability
artículo científico publicado en 2020
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
artículo científico publicado en 2018
A new procedure for detecting brain-specific proteins in cerebrospinal fluid
scientific article published on 01 January 1997
A new putative principle for diagnosis of Creutzfeldt-Jakob disease
artículo científico publicado en 2002
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease
artículo científico publicado en 2012
A novel ARC polymorphism is associated with reduced risk of Alzheimer's disease
scholarly article by Petronella Kettunen et al published July 2010 in Alzheimer's and Dementia
A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease
artículo científico publicado en 2010
A novel pathway for amyloid precursor protein processing
artículo científico publicado en 2009
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
artículo científico publicado en 2017
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
artículo científico publicado en 2015
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
artículo científico publicado en 2009
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
artículo científico publicado en 2017
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
artículo científico publicado en 1998
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia
artículo científico publicado en 1998
A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
artículo científico publicado en 1995
A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease
scientific article published on 01 November 1999
A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.
artículo científico publicado en 2013
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
artículo científico publicado en 2016
A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals
artículo científico publicado en 2015
A survey of ABCA1 sequence variation confirms association with dementia
scientific article published on September 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
artículo científico publicado en 2009
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
artículo científico publicado en 2016
ALCOHOLICS WITH THE DOPAMINE RECEPTOR DRD2 A1 ALLELE HAVE LOWER PLATELET MONOAMINE OXIDASE-B ACTIVITY THAN THOSE WITH THE A2 ALLELE: A PRELIMINARY STUDY
artículo científico publicado en 2000
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
artículo científico publicado en 2015
APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.
artículo científico publicado en 2004
APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease
artículo científico publicado en 2016
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease
artículo científico publicado en 2020
APOE-ε4 Shapes the Cerebral Organization in Cognitively Intact Individuals as Reflected by Structural Gray Matter Networks
artículo científico publicado en 2020
APP metabolism regulates tau proteostasis in human cerebral cortex neurons
artículo científico publicado en 2015
Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
artículo científico publicado en 2018
Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study
artículo científico publicado en 2016
Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
artículo científico publicado en 2017
Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons
scientific article published on 17 January 2020
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders
artículo científico publicado en 2012
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography
artículo científico publicado en 2014
Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay
artículo científico publicado en 2017
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
scholarly article by Sebastian Palmqvist et al published 23 October 2018 in Alzheimer's and Dementia
Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers
artículo científico publicado en 2013
Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs
artículo científico publicado en 2010
Acute symptomatic seizures and epilepsy after mechanical thrombectomy
artículo científico publicado en 2019
Additional evidence for antagonistic pleiotropic effects of APOE
artículo científico publicado en 2009
Admission Levels of Total Tau and β-Amyloid Isoforms 1-40 and 1-42 in Predicting the Outcome of Mild Traumatic Brain Injury
artículo científico publicado en 2020
Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers
artículo científico publicado en 2003
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit
artículo científico publicado en 2012
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
artículo científico publicado en 2014
Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology
artículo científico publicado en 2019
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study
scientific article published on 20 August 2020
Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid
artículo científico publicado en 2018
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels
artículo científico publicado en 2014
Alterations in the Balance of Amyloid-β Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients
artículo científico publicado en 2017
Altered blood-brain-barrier function in Alzheimer's disease?
artículo científico publicado en 1994
Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome
artículo científico publicado en 2014
Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder
artículo científico publicado en 2012
Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease
artículo científico publicado en 2012
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
artículo científico publicado en 2004
Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.
artículo científico publicado en 2003
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study
artículo científico publicado en 2004
Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard
artículo científico publicado en 2013
Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate
artículo científico publicado en 2017
Alzheimer's disease
artículo científico publicado en 2006
Alzheimer's disease
artículo científico publicado en 2016
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
artículo científico publicado en 2018
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
artículo científico publicado en 2015
Alzheimer's disease markers in the aged sheep (Ovis aries).
artículo científico publicado en 2017
Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly
artículo científico publicado en 2011
Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria
artículo científico publicado en 2015
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
artículo científico publicado en 2016
Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk
artículo científico publicado en 2009
Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
scholarly article by Bruno Becker published in August 2018
Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment
artículo científico publicado en 2005
Amyloid and Tau Biomarkers in CSF.
artículo científico publicado en 2015
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
artículo científico publicado en 2009
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury
artículo científico publicado en 2004
Amyloid beta and APP as biomarkers for Alzheimer's disease
scientific article published on 19 August 2009
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization
artículo científico publicado en 2008
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
artículo científico publicado en 2020
Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods
artículo científico publicado en 2007
Amyloid biomarkers in Alzheimer's disease
artículo científico publicado en 2015
Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus
scientific article published on 29 July 2016
Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease
artículo científico publicado en 2017
Amyloid precursor like protein 1 in Idiopathic Normal Pressure hydrocephalus; expanding the knowledge of an altered amyloid metabolism.
artículo científico publicado en 2015
Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation
artículo científico publicado en 2016
Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death
scientific article published on 10 April 2019
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
artículo científico publicado en 2011
Amyloid-β associated volume loss occurs only in the presence of phospho-tau
artículo científico publicado en 2011
Amyloid-β metabolism in Niemann-Pick C disease models and patients
artículo científico publicado en 2012
Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease
artículo científico publicado en 2012
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease
artículo científico publicado en 2012
Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment
artículo científico
An 18-year follow-up of overweight and risk of Alzheimer disease
artículo científico publicado en 2003
An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid
artículo científico publicado en 2006
An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease
artículo científico publicado en 2014
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid
artículo científico publicado en 2012
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
scientific article published on 22 April 2020
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead
scientific article published on 12 December 2019
Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis
artículo científico publicado en 1999
Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk
artículo científico publicado en 2010
Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry
artículo científico publicado en 2005
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method
artículo científico publicado en 2020
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
artículo científico publicado en 2006
Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803-810 (2014).
artículo científico publicado en 2014
Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment
artículo científico publicado en 2011
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment
artículo científico publicado en 2012
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease
artículo científico publicado en 2014
Apolipoprotein E genotypes and longevity across dementia disorders.
artículo científico publicado en 2018
Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
artículo científico publicado en 1996
Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions
artículo científico publicado en 1997
Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury
artículo científico publicado en 2008
Apolipoprotein E polymorphism in aneurysmal subarachnoid haemorrhage in West Sweden
artículo científico publicado en 2015
Apolipoprotein E polymorphism in patients with cataract
artículo científico publicado en 2004
Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.
artículo científico publicado en 2007
Aspects of beta-amyloid as a biomarker for Alzheimer's disease
artículo científico publicado en 2007
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
article
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
scientific article published on 01 July 2019
Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years
scientific article published on 04 October 2016
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
artículo científico publicado en 2006
Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis
artículo científico publicado en 2012
Association between thyroid hormone levels and monoaminergic neurotransmission during surgery
scientific article published on 10 September 2007
Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.
artículo científico publicado en 2008
Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease
artículo científico publicado en 2016
Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease
scientific article published on 06 May 2019
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
artículo científico publicado en 2017
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
artículo científico publicado en 2015
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
scientific article published on 01 March 2019
Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment
scientific article published on 01 February 2019
Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery: Results From the CAPACITY and ARCADIAN Studies
artículo científico publicado en 2018
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
artículo científico publicado en 2010
Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.
artículo científico publicado en 2018
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
artículo científico publicado en 2017
Association of brain network dynamics with plasma biomarkers in subjective memory complainers
artículo científico publicado en 2019
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers
artículo científico publicado en 2018
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease
artículo científico publicado en 2008
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults
artículo científico publicado en 2017
Association of nAChR gene haplotypes with heavy alcohol use and body mass
artículo científico publicado en 2009
Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass
artículo científico publicado en 2008
Association of the RAGE G82S polymorphism with Alzheimer's disease
artículo científico publicado en 2010
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease
artículo científico publicado en 2016
Astroglial activation and altered amyloid metabolism in human repetitive concussion
artículo científico publicado en 2017
Author Correction: Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons
scientific article published on 28 February 2020
Author response: Calcium supplementation and risk of dementia in women with cerebrovascular disease.
artículo científico publicado en 2017
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
scientific article published on 08 October 2019
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections
artículo científico publicado en 2013
Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases
artículo científico publicado en 2012
Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease
artículo científico publicado en 2010
BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
artículo científico publicado en 2010
BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system
artículo científico publicado en 2012
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem
artículo científico publicado en 2015
Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster
artículo científico publicado en 2016
Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease
artículo científico publicado en 2002
Biochemical markers in Alzheimer's disease clinical trials
artículo científico publicado en 2010
Biological CSF markers of Alzheimer's disease
artículo científico publicado en 2008
Biological correlates of clinical subgroups of Alzheimer's disease
artículo científico publicado en 2002
Biological markers of amyloid beta-related mechanisms in Alzheimer's disease
artículo científico publicado en 2010
Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife
artículo científico
Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease
artículo científico publicado en 2012
Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab
artículo científico publicado en 2018
Biomarker-based dissection of neurodegenerative diseases
scientific article published on 16 April 2011
Biomarker-guided clustering of Alzheimer's disease clinical syndromes
artículo científico publicado en 2019
Biomarkers for Alzheimer's disease therapeutic trials
artículo científico publicado en 2010
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
scientific article published on July 2010
Biomarkers for Alzheimer's: the sequel of an original model
artículo científico publicado en 2013
Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study
artículo científico publicado en 2018
Biomarkers for microglial activation in Alzheimer's disease
artículo científico publicado en 2011
Biomarkers for tau pathology.
artículo científico publicado en 2018
Biomarkers in Sporadic and Familial Alzheimer's Disease
artículo científico
Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease
artículo científico publicado en 2013
Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review
scholarly article by Ulla Knorr et al published July 2018 in European Neuropsychopharmacology
Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis
artículo científico publicado en 2009
Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood
artículo científico publicado en 2013
Blood Biomarkers: Democratizing Alzheimer's Diagnostics
scientific article published on 01 June 2020
Blood biomarkers for brain injury in concussed professional ice hockey players.
artículo científico publicado en 2014
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving
artículo científico publicado en 2016
Blood brain barrier function in vascular dementia.
artículo científico publicado en 1990
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
artículo científico publicado en 2020
Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly
scientific article published on 19 August 2013
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
artículo científico publicado en 2017
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
artículo científico publicado en 2018
Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study.
artículo científico publicado en 2018
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors
artículo científico publicado en 1990
Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment
artículo científico publicado en 2014
Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease
artículo científico publicado en 2011
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
artículo científico publicado en 2011
Both total and phosphorylated tau are increased in Alzheimer's disease
artículo científico publicado en 2001
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry
artículo científico publicado en 2015
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure
artículo científico publicado en 2020
Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.
artículo científico publicado en 2010
Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor
artículo científico publicado en 2015
Brain monoaminergic and neuropeptidergic variations in human aging
scientific article published on 01 January 1996
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
artículo científico publicado en 2017
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
artículo científico publicado en 2015
C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning
artículo científico publicado en 2016
CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder
artículo científico publicado en 2015
CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage
artículo científico publicado en 2006
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation
artículo científico publicado en 2016
CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
artículo científico publicado en 2013
CSF Aβ42 predicts early-onset dementia in Parkinson disease
artículo científico publicado en 2014
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
artículo científico publicado en 2016
CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease
artículo científico publicado en 2012
CSF YKL-40 and GAP-43 are related to suicidal ideation in older women
artículo científico publicado en 2017
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex
artículo científico publicado en 2005
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
artículo científico publicado en 2010
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study
artículo científico publicado en 2010
CSF and blood biomarkers for Parkinson's disease
scientific article published on 10 April 2019
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
artículo científico publicado en 2016
CSF antithrombin III and disruption of the blood-brain barrier
artículo científico publicado en 2009
CSF biomarker variability in the Alzheimer's Association quality control program
artículo científico publicado en 2013
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
artículo científico publicado en 2009
CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly
artículo científico publicado en 2012
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics
artículo científico publicado en 2019
CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival
artículo científico publicado en 2006
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment
artículo científico publicado en 2005
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.
artículo científico publicado en 2013
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
artículo científico publicado en 2005
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.
artículo científico publicado en 2015
CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
artículo científico publicado en 2007
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
artículo científico publicado en 2018
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
artículo científico publicado en 2010
CSF biomarkers: pinpointing Alzheimer pathogenesis
scientific article published on October 2009
CSF in Alzheimer's disease.
artículo científico publicado en 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment
scientific article published on 13 February 2014
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
artículo científico publicado en 2010
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
artículo científico publicado en 2020
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
artículo científico publicado en 2000
CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42
⬇️
artículo científico publicado el 1 de octubre de 2003
CSF markers for incipient Alzheimer's disease
artículo científico publicado en 2003
CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry
artículo científico publicado en 2003
CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
artículo científico publicado en 2017
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
artículo científico publicado en 2014
CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults
artículo científico publicado en 2016
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD
artículo científico publicado en 2019
CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
artículo científico publicado en 2018
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment
artículo científico publicado en 2015
CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
artículo científico publicado en 2016
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
scientific article published on 08 December 2019
CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
scholarly article by Kristi Henjum et al published 3 November 2018 in Journal of Neuroinflammation
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy
artículo científico publicado en 2000
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia
scientific article published on 17 December 2019
CSF tau and β-amyloid as biomarkers for mild cognitive impairment.
artículo científico publicado en 2004
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
artículo científico publicado en 2002
CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
artículo científico publicado en 2001
CSF α-synuclein correlates with CSF neurogranin in late-life depression
scientific article published on 31 March 2020
CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma
artículo científico publicado en 2012
CSF-methionine is elevated in psychotic patients
artículo científico publicado en 2004
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients
artículo científico
CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study
artículo científico publicado en 2020
Calcium supplementation and risk of dementia in women with cerebrovascular disease
artículo científico publicado en 2016
Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue
artículo científico publicado en 1990
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
artículo científico publicado en 2009
Cardiac Surgery is Associated with Biomarker Evidence of Neuronal Damage
artículo científico publicado en 2020
Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition
artículo científico publicado en 2015
Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort
artículo científico publicado en 2019
Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD.
artículo científico publicado en 2017
Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition
artículo científico publicado en 2015
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
article published in 2019
Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change
artículo científico publicado en 2017
Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients
artículo científico publicado en 2003
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias
artículo científico publicado en 2003
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET
artículo científico publicado en 2016
Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults
artículo científico publicado en 2020
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease
artículo científico publicado en 2016
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease
artículo científico publicado en 2016
Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction
artículo científico publicado en 2015
Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type
artículo científico publicado en 2018
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team
artículo científico publicado en 2017
Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease
artículo científico publicado en 2020
Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease
artículo científico publicado en 2019
Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease
scientific article published on 01 January 2019
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
article
Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years
artículo científico publicado en 2015
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
artículo científico publicado en 2020
Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
artículo científico
Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease
artículo científico publicado en 2016
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
artículo científico publicado en 2017
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
artículo científico publicado en 2015
Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium
artículo científico publicado en 2017
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
artículo científico publicado en 2016
Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study
scientific article published on 17 June 2020
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage
artículo científico publicado en 2018
Cerebrospinal Fluid ‘Neuronal Thread Protein’ Comes from Serum by Passage over the Blood-Brain Barrier
⬇️
artículo científico publicado el 1 de junio de 1995
Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease
artículo científico publicado en 2013
Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
artículo científico publicado en 2003
Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
artículo científico publicado en 2012
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
artículo científico publicado en 2013
Cerebrospinal fluid GAP-43 in early multiple sclerosis
Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease
artículo científico publicado en 2007
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
artículo científico publicado en 2008
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease
artículo científico publicado en 2012
Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?
artículo científico publicado en 2013
Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments
artículo científico
Cerebrospinal fluid analysis should be considered in patients with cognitive problems
artículo científico publicado en 2010
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
artículo científico publicado en 2017
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
scientific article published on 11 November 2019
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
artículo científico publicado en 2010
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
scientific article published on 18 June 2020
Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition
scientific article published on 22 October 2019
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimerʼs disease
⬇️
artículo científico publicado el 20 de diciembre de 1994
Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women
artículo científico publicado en 2006
Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds
artículo científico publicado en 2003
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
artículo científico publicado en 1999
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses
artículo científico publicado en 2010
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
artículo científico publicado en 2009
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
artículo científico publicado en 2016
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
scientific article published on 14 October 2013
Cerebrospinal fluid biomarkers for Alzheimer's disease
artículo científico publicado en 2009
Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?
artículo científico
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population
artículo científico publicado en 2011
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.
artículo científico publicado en 2017
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis
scientific article published on 15 February 2019
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice
artículo científico publicado en 2016
Cerebrospinal fluid biomarkers in cardiac arrest survivors
artículo científico publicado en 2013
Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections
artículo científico publicado en 2013
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
artículo científico publicado en 2014
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
artículo científico publicado en 2016
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease
scientific article published on 06 May 2020
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
artículo científico publicado en 2019
Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
artículo científico publicado en 2018
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study
artículo científico publicado en 2009
Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.
artículo científico publicado en 2013
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis
scientific article published on 15 October 2012
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.
artículo científico publicado en 2007
Cerebrospinal fluid brain injury biomarkers in children: a multicenter study
artículo científico publicado en 2013
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis
artículo científico publicado en 2007
Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis
artículo científico publicado en 2019
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
artículo científico publicado en 2018
Cerebrospinal fluid insulin during non-neurological surgery
artículo científico publicado en 2010
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals
artículo científico
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
artículo científico publicado en 2002
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
article
Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease
artículo científico publicado en 2004
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
article
Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia
artículo científico publicado en 2013
Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women
artículo científico publicado en 2016
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
artículo científico publicado en 2016
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
scientific article published on 13 December 2019
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
artículo científico publicado en 2014
Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
scientific article published on 01 January 2003
Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
artículo científico publicado en 2012
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
artículo científico publicado en 2020
Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus
artículo científico
Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.
artículo científico publicado en 2000
Cerebrospinal fluid markers for prediction of Alzheimer's disease
⬇️
artículo científico publicado el 27 de noviembre de 2003
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
artículo científico publicado en 2014
Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery
artículo científico publicado en 2012
Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study
artículo científico publicado en 2015
Cerebrospinal fluid markers of extracellular matrix remodeling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy.
artículo científico publicado en 2018
Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies
artículo científico publicado en 2017
Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis
artículo científico publicado en 2016
Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype
artículo científico publicado en 1999
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease
artículo científico publicado en 2011
Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
artículo científico publicado en 2016
Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.
artículo científico publicado en 2011
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls
artículo científico publicado en 2017
Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
artículo científico publicado en 1996
Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age
⬇️
artículo científico publicado el 1 de marzo de 1993
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
artículo científico publicado en 2019
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
artículo científico publicado en 2019
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
artículo científico publicado en 2017
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
scientific article published on 27 February 2020
Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients
scientific article published on 09 July 2018
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype
artículo científico publicado en 2007
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
artículo científico publicado en 2018
Cerebrospinal fluid neurogranin and TREM2 in Huntington's disease.
artículo científico publicado en 2018
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
artículo científico publicado en 2015
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
artículo científico publicado en 2018
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration
scientific article published on 25 October 2019
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease
artículo científico publicado en 2015
Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia
artículo científico publicado en 1995
Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia
artículo científico publicado en 2002
Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease
artículo científico publicado en 2012
Cerebrospinal fluid protein biomarkers for Alzheimer's disease
artículo científico publicado en 2004
Cerebrospinal fluid protein reactions during non-neurological surgery
artículo científico publicado en 2007
Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation
artículo científico publicado en 2016
Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.
artículo científico publicado en 2018
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease
artículo científico publicado en 2009
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability
artículo científico publicado en 2010
Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease
artículo científico publicado en 2014
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.
artículo científico publicado en 2015
Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
scientific article published on 01 September 1999
Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1.
artículo científico publicado en 2008
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
artículo científico publicado en 2015
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders
artículo científico publicado en 2001
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
artículo científico publicado en 2020
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study
artículo científico publicado en 1998
Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration
article
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
scientific article published on 17 August 2016
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
artículo científico publicado en 2010
Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.
artículo científico publicado en 2009
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease
artículo científico publicado en 2020
Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities.
artículo científico publicado en 2018
Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
artículo científico publicado en 2016
Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy
artículo científico publicado en 2014
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
artículo científico publicado en 2010
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
artículo científico publicado en 2015
Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
artículo científico publicado en 2012
Characterization of Cerebrospinal Fluid BACE1 Species
scientific article published on 09 July 2019
Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
artículo científico publicado en 2007
Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease
artículo científico publicado en 2013
Characterization of proteins from human cerebrospinal fluid by a combination of preparative two-dimensional liquid-phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
artículo científico publicado en 1999
Characterization of tau in cerebrospinal fluid using mass spectrometry.
artículo científico publicado en 2008
Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice.
artículo científico publicado en 2011
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
artículo científico publicado en 2015
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
artículo científico publicado en 2019
Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?
artículo científico publicado en 1995
Chronic traumatic encephalopathy: fluid biomarkers
artículo científico publicado en 2018
Circulating Aβ40 influences plasma BDNF levels and white matter integrity
Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction
scientific article published on 02 August 2019
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
artículo científico publicado en 2007
Clearance systems in the brain--implications for Alzheimer diseaser.
artículo científico publicado en 2016
Clearance systems in the brain-implications for Alzheimer disease
artículo científico publicado en 2015
Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations
artículo científico publicado en 2001
Clinical diagnosis of Alzheimer's disease by primary care physicians and specialists
artículo científico publicado el 1 de enero de 1992
Clinical heterogeneity of probable Alzheimer's disease
artículo científico publicado el 1 de abril de 1992
Clinical mass spectrometry in neuroscience. Proteomics and peptidomics
artículo científico publicado en 2003
Clinical proteomics in neurodegenerative disorders
artículo científico publicado en 2008
Clinical subgroups of the Alzheimer syndrome.
artículo científico publicado en 1996
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
artículo científico publicado en 2014
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
artículo científico publicado en 2017
Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease
artículo científico publicado en 1998
Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms
artículo científico publicado en 2006
Coagulation of cerebrospinal fluid--the Nonne-Froin sign.
artículo científico publicado en 2013
Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls
artículo científico publicado en 2015
Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.
artículo científico publicado en 2010
Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.
artículo científico publicado en 1998
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease
artículo científico publicado en 2007
Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".
artículo científico publicado en 2014
Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
artículo científico publicado en 2018
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
artículo científico publicado en 2021
Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease
artículo científico publicado en 2004
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
scientific article published on 01 November 2018
Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats
artículo científico publicado en 2003
Comparative proteome analysis of thalamus in MK-801-treated rats
artículo científico publicado en 2004
Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
artículo científico publicado en 2018
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
artículo científico publicado en 2016
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study
artículo científico publicado en 2012
Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
scientific article published on 10 June 2019
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial
scientific article published on 05 March 2019
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
artículo científico publicado en 2016
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin
scientific article published on 23 October 2019
Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder
scientific article published on 13 November 2019
Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease
artículo científico publicado en 2013
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
artículo científico publicado en 2016
Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease
artículo científico publicado en 2009
Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid
⬇️
artículo científico publicado el 1 de enero de 1993
Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease
artículo científico publicado en 2009
Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
artículo científico publicado en 2017
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid
artículo científico publicado en 2010
Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease
artículo científico publicado en 1990
Consensus guidelines for lumbar puncture in patients with neurological diseases
artículo científico publicado en 2017
Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.
artículo científico publicado en 2005
Converging molecular pathways in human neural development and degeneration
artículo científico publicado en 2009
Converging pathways of chromogranin and amyloid metabolism in the brain
artículo científico publicado en 2010
Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity
artículo científico publicado en 2003
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
artículo científico publicado en 2007
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
scientific article published on 18 January 2020
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
scholarly article published in Alzheimers Research & Therapy
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau
scientific article published on 01 April 2019
Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury
artículo científico publicado en 2019
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
artículo científico publicado en 2010
Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults
artículo científico publicado en 2013
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
scientific article published on 01 September 2019
Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].
artículo científico publicado en 2016
Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease
artículo científico publicado en 2008
Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe
artículo científico publicado en 2017
Current state of Alzheimer's fluid biomarkers
scholarly article by José Luis Molinuevo et al published 1 December 2018 in Acta Neuropathologica
Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
scholarly article by Johan Sundelöf et al published 11 August 2010 in Journal of Alzheimer's Disease
Cystatin C in cerebrospinal fluid and multiple sclerosis
artículo científico publicado en 2007
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
artículo científico publicado en 2000
Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species
artículo científico publicado en 2018
Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
artículo científico publicado en 2002
Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia
⬇️
artículo científico publicado el 1 de enero de 2003
Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder
artículo científico publicado en 2013
Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis
artículo científico publicado en 2018
Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease
artículo científico publicado en 2001
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
artículo científico publicado en 2004
Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia
artículo científico publicado en 1996
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease
artículo científico publicado en 1998
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain
artículo científico publicado en 1999
Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
artículo científico publicado en 2016
Delirium in dementia
artículo científico publicado en 1998
Dementia and CSF-biomarkers for Alzheimer's disease predict mortality after acute hip fracture
artículo científico publicado en 2019
Dementia in 2010: Paving the way for Alzheimer disease drug development
artículo científico publicado en 2011
Dementia. It's getting better all the time
scientific article published on 01 December 1998
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
artículo científico publicado en 2015
Detection and quantification of novel tau/phospho-tau epitopes in CSF using a multiplex assay approach
Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystem
artículo científico publicado en 1995
Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients
scientific article published on 15 November 2019
Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
artículo científico publicado en 2006
Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges
artículo científico
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
artículo científico publicado en 2012
Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease
artículo científico publicado en 2019
Dextran- versus crystalloid-based prime in cardiac surgery: A prospective randomized pilot study
scientific article published on 14 April 2020
Diagnosis of Dementias Using Partial Least Squares Discriminant Analysis
⬇️
artículo científico publicado el 1 de marzo de 1995
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
artículo científico publicado en 2010
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
artículo científico publicado en 2019
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
artículo científico publicado en 2014
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
artículo científico publicado en 2017
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
artículo científico publicado en 2020
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry
artículo científico publicado en 2014
Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health
artículo científico publicado en 2013
Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease
artículo científico publicado en 2005
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
artículo científico publicado en 2020
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
artículo científico publicado en 2020
Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma
scientific article published on 19 August 2018
Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus
artículo científico publicado en 2004
Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging
artículo científico publicado el 1 de diciembre de 1992
Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients
scientific article published on 01 January 1996
Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects
artículo científico publicado en 2007
Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.
artículo científico publicado en 2006
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
artículo científico publicado en 2002
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
artículo científico publicado en 2001
Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
artículo científico publicado en 2010
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
artículo científico publicado en 2019
Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases
artículo científico publicado en 2011
Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis
artículo científico publicado en 2015
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease
scientific article published on 25 June 2020
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease
artículo científico publicado en 2006
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
artículo científico publicado en 2010
Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study.
artículo científico publicado en 2011
Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
artículo científico publicado en 2015
Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals
artículo científico publicado en 2009
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
artículo científico publicado en 2013
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
scientific article published on 01 June 2019
Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury
scientific article published on 01 September 2019
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
artículo científico publicado en 2017
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury
scientific article published on 08 January 2019
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study
scholarly article by David Bäckström et al published 31 October 2018 in Neurology
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.
artículo científico publicado en 2016
Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease
artículo científico publicado en 2007
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration
artículo científico publicado en 2017
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease
artículo científico
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
artículo científico publicado en 2008
Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
artículo científico publicado en 2017
Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease
artículo científico publicado en 2006
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease
scientific article published on 11 July 2018
Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid
artículo científico publicado en 2017
Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men
scientific article published on 08 January 2020
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
artículo científico publicado en 2010
Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease
artículo científico publicado en 2009
Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology
artículo científico publicado en 2009
Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial
scholarly article by Mattias Danielson et al published 27 September 2018 in Journal of Neuroinflammation
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study
artículo científico publicado en 2017
Effects on rat thalamic proteome by acute and subchronic MK-801-treatment
artículo científico publicado en 2004
Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression
artículo científico publicado en 2017
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
artículo científico publicado en 2018
Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
artículo científico publicado en 2011
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
artículo científico publicado en 2008
Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients
artículo científico publicado en 2006
Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis
artículo científico publicado en 2008
Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients
artículo científico publicado en 2014
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
artículo científico publicado en 2005
Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
artículo científico publicado en 2008
Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease
scientific article published on 23 June 2020
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data
artículo científico publicado en 2017
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease
artículo científico publicado en 2012
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
scientific article published on 14 September 2019
Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force
artículo científico publicado en 2015
Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
artículo científico publicado en 2008
Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease
artículo científico publicado en 2019
Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease
artículo científico publicado en 2013
Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
scholarly article by Joakim Hertze et al published 10 September 2010 in Journal of Alzheimer's Disease
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years
artículo científico publicado en 2010
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease
artículo científico publicado en 2001
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice
artículo científico publicado en 2001
Evaluation of factors of importance for clinical dementia diagnosis
artículo científico publicado en 2005
Evaluation of neprilysin sequence variation in relation to CSF β-Amyloid levels and Alzheimer disease risk
artículo científico publicado en 2010
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
artículo científico publicado en 2008
Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study
artículo científico publicado en 2012
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
scholarly article by Oskar Hansson et al published April 2010 in Neurobiology of Aging
Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment
artículo científico publicado en 2007
Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders
artículo científico publicado en 2013
Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient
artículo científico publicado en 2012
Evidence that the gene encoding insulin degrading enzyme influences human lifespan
artículo científico publicado en 2008
Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup
artículo científico publicado en 2005
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment
artículo científico publicado en 2009
Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease
artículo científico publicado en 2018
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
artículo científico publicado en 2015
Evolving Relevance of Neuroproteomics in Alzheimer's Disease
artículo científico publicado en 2017
Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
artículo científico publicado en 2017
Exhaled endogenous particles contain lung proteins
artículo científico publicado en 2011
Expanding the cerebrospinal fluid endopeptidome
artículo científico publicado en 2017
Explorative and targeted neuroproteomics in Alzheimer's disease
artículo científico publicado en 2015
Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid
artículo científico publicado en 2014
Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons
artículo científico publicado en 2018
Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference.
artículo científico publicado en 2011
Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials
artículo científico publicado en 2012
Factors Influencing Successful Lumbar Puncture in Alzheimer Research
artículo científico publicado en 2017
Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta
scientific article published on 12 April 2019
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain
artículo científico publicado en 2014
First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression
artículo científico publicado en 2015
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
artículo científico publicado en 2018
Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings
scientific article published on 24 July 2019
Fluid biomarkers for mild traumatic brain injury and related conditions
artículo científico publicado en 2016
Fluid biomarkers in Alzheimer disease
artículo científico publicado en 2012
Fluid biomarkers in Alzheimer's disease - current concepts
artículo científico publicado en 2013
Fluid markers of traumatic brain injury
artículo científico
Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis
artículo científico publicado en 1994
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease
artículo científico publicado en 2018
Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease
artículo científico publicado en 2013
Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.
artículo científico publicado en 2003
Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype
artículo científico publicado en 2001
GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology
artículo científico publicado en 2018
Gamma-glutamyltransferase in alcohol use disorders: Modification of decision limits in relation to treatment goals?
artículo científico publicado en 2010
Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study
artículo científico publicado en 2010
Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis
artículo científico publicado en 1997
Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.
artículo científico publicado en 1991
Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion
artículo científico publicado en 2003
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.
artículo científico publicado en 2005
Genetic association of sequence variants near AGER/NOTCH4 and dementia
artículo científico publicado en 2011
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism
artículo científico publicado en 2004
Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function
artículo científico publicado en 2015
Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease
artículo científico publicado en 2004
Genetic variation in FOXO3 is associated with self-rated health in a population-based sample of older individuals.
artículo científico publicado en 2018
Genetic variation in a haplotype block spanningIDE influences Alzheimer disease
⬇️
artículo científico publicado el 1 de noviembre de 2003
Genetic variation of the ghrelin signaling system in females with severe alcohol dependence
artículo científico publicado en 2010
Genome-wide association study identifies MAPT locus influencing human plasma tau levels
artículo científico publicado en 2017
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers
artículo científico publicado en 2017
Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls
scientific article published on 05 February 2020
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism
artículo científico publicado en 2016
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
artículo científico publicado en 2016
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
artículo científico publicado en 2015
Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.
artículo científico publicado en 1996
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium
artículo científico publicado en 2012
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
artículo científico publicado en 2003
Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease
artículo científico publicado en 2015
Growth factors and neurotrophins in patients with stress-related exhaustion disorder
scientific article published on 20 August 2019
Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.
artículo científico publicado en 2000
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
artículo científico publicado en 2015
Gut microbiome alterations in Alzheimer's disease
artículo científico publicado en 2017
Haplotypes extending across ACE are associated with Alzheimer's disease
artículo científico publicado en 2003
Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.
artículo científico publicado en 2001
Harmonized diagnostic criteria for Alzheimer's disease: recommendations
artículo científico publicado en 2014
Head size may modify the impact of white matter lesions on dementia
artículo científico publicado en 2011
Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics
artículo científico publicado en 2018
Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration
artículo científico publicado en 2013
Heterogeneity of vascular dementia: mechanisms and subgroups
artículo científico publicado en 1993
High education may offer protection against tauopathy in patients with mild cognitive impairment
artículo científico publicado en 2010
High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
artículo científico publicado en 2016
High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS.
artículo científico publicado en 2017
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample
artículo científico publicado en 2014
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls
scholarly article by Johan Sundelöf et al published 7 January 2011 in Journal of Alzheimer's Disease
Histology-Compatible MALDI Mass Spectrometry Based Imaging of Neuronal Lipids for Subsequent Immunofluorescent Staining.
artículo científico publicado en 2017
Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments
Human plasma biomarker responses to inhalational general anaesthesia without surgery
artículo científico publicado en 2020
Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium
artículo científico publicado en 2001
Hypothalamic dysfunction in dementia
artículo científico publicado en 1994
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans
artículo científico publicado en 2011
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.
artículo científico publicado en 2005
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.
artículo científico publicado en 2007
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
artículo científico publicado en 2017
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain
artículo científico publicado en 2019
Identification of novel APP/Abeta isoforms in human cerebrospinal fluid
artículo científico publicado en 2009
Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid
artículo científico publicado en 2009
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method
artículo científico publicado en 2011
Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry
Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry
artículo científico publicado en 1999
Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry
artículo científico publicado en 2002
Identification of synaptic vesicle, pre- and postsynaptic proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing
artículo científico publicado en 1999
Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry
artículo científico publicado en 2001
Identification of tissue-specific cell death using methylation patterns of circulating DNA
artículo científico publicado en 2016
Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers
artículo científico publicado en 2013
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.
artículo científico publicado en 2007
Imatinib treatment and Aβ42 in humans.
artículo científico publicado en 2013
Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age
artículo científico publicado en 1996
Immunomodulating and anti-inflammatory properties of the sympatholytic compound 6-hydroxydopamine
scientific article published on 01 December 1994
Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio
artículo científico publicado en 2015
Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease
⬇️
artículo científico publicado el 1 de enero de 2011
Impaired synaptic function is linked to cognition in Parkinson's disease
artículo científico publicado en 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
artículo científico publicado en 2017
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.
artículo científico publicado en 1999
Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome.
artículo científico publicado en 2007
Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia
artículo científico
Increased CSF biomarkers of angiogenesis in Parkinson disease
artículo científico publicado en 2015
Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers
artículo científico publicado en 2013
Increased CSF neurogranin concentration is specific to Alzheimer disease
artículo científico publicado en 2016
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
artículo científico publicado en 2008
Increased CSF/serum albumin ratio: a recurrent finding in violent offenders
artículo científico publicado en 2005
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
artículo científico publicado en 2015
Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
scientific article published on May 2016
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
artículo científico publicado en 2014
Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment
artículo científico publicado en 2017
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42
scientific article published on 08 March 2019
Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia
artículo científico publicado en 2002
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
artículo científico publicado en 2016
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
artículo científico publicado en 2016
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
artículo científico publicado en 2014
Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease
artículo científico publicado en 2004
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
artículo científico publicado en 2016
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
article
Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos
artículo científico publicado en 2002
Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications
artículo científico publicado en 2004
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia
scientific article published on 01 March 2002
Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment
artículo científico publicado en 2005
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study
artículo científico publicado en 2017
Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later
artículo científico publicado en 2017
Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
artículo científico publicado en 2016
Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease
artículo científico publicado en 2014
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
scholarly article by Nicholas J Ashton et al published 9 January 2019 in Acta neuropathologica communications
Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease.
artículo científico publicado en 1995
Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis
⬇️
artículo científico publicado el 6 de octubre de 2003
Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome
artículo científico publicado en 2005
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
artículo científico publicado en 2007
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
artículo científico publicado en 2014
Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.
artículo científico publicado en 2018
Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition
artículo científico publicado en 2017
Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease
artículo científico publicado en 2003
Influence of the apolipoprotein E epsilon4 allele on human embryonic development.
artículo científico publicado en 2002
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury
artículo científico publicado en 2006
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
artículo científico publicado en 2012
Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers
artículo científico publicado en 2015
Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults
artículo científico publicado en 2016
Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
artículo científico publicado en 2010
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals
artículo científico publicado en 2013
Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women
artículo científico publicado en 2011
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury
artículo científico publicado en 2020
Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.
artículo científico publicado en 1990
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.
artículo científico publicado en 2007
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia
artículo científico publicado en 1999
Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients
scientific article published on 01 January 1997
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity
artículo científico publicado en 2017
Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease
artículo científico publicado en 2015
Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
artículo científico
Intrathecal inflammation precedes development of Alzheimer's disease
artículo científico publicado en 2003
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement
artículo científico publicado en 2004
Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia
scientific article published on 01 November 2000
Intrathecal synthesis of immunoglobulin G in vascular dementia
artículo científico publicado en 1990
Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease
artículo científico publicado en 1990
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
artículo científico publicado en 2013
Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
artículo científico publicado en 2010
Is there a CSF biomarker profile related to depression in elderly women?
artículo científico publicado en 2010
KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD
artículo científico publicado en 2019
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
artículo científico publicado en 2007
Kinesin light chain 1 gene haplotypes in three conformational diseases.
artículo científico publicado en 2009
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
artículo científico publicado en 2001
Laboratory testing for lyme neuroborreliosis
artículo científico publicado en 2015
Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease
artículo científico publicado en 2001
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
artículo científico publicado en 2010
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study
artículo científico publicado en 2011
Levels of ADAM10 are reduced in Alzheimer's disease CSF
scientific article published on 25 July 2018
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
artículo científico publicado en 2007
Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants
artículo científico publicado en 2011
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease
artículo científico publicado en 2014
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia
artículo científico publicado en 2001
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
artículo científico publicado en 2016
Longitudinal Performance of Plasma Neurofilament Light and Tau in Professional Fighters: The Professional Fighters Brain Health Study
article
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
artículo científico publicado en 2015
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
scientific article published on 06 April 2019
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment
artículo científico publicado en 2012
Longitudinal change in regional brain volumes with exposure to repetitive head impacts
scientific article published on 23 December 2019
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease
scholarly article by Philip S J Weston et al published 20 February 2019 in Alzheimers Research & Therapy
Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
artículo científico publicado en 2012
Longitudinal stability of CSF biomarkers in Alzheimer's disease.
artículo científico publicado en 2007
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease
artículo científico publicado en 2009
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease
Longstanding psychological stress in relation to biomarkers of neuronal dysfunction in cerebrospinal fluid: a 25-year follow-up study in women
artículo científico publicado en 2019
Losing the identity of a hockey player: the long-term effects of concussions
artículo científico publicado en 2020
Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.
artículo científico publicado en 2018
Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke
artículo científico publicado en 2016
Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?
artículo científico publicado en 1993
Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment
artículo científico publicado en 2001
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study
artículo científico publicado en 2012
Low frequency of post-lumbar puncture headache in demented patients
scientific article published on 01 September 1993
Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients
artículo científico publicado en 2010
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease
artículo científico publicado en 2020
Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.
artículo científico publicado en 2006
Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.
artículo científico publicado en 2017
Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD.
artículo científico publicado en 2009
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder
artículo científico publicado en 2012
Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years
artículo científico publicado en 2013
Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults
artículo científico publicado en 2020
Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease
artículo científico publicado en 2013
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse
artículo científico publicado en 2012
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease
artículo científico publicado en 2009
Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
artículo científico publicado en 2004
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
artículo científico publicado en 2017
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
artículo científico publicado en 2017
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease
scientific article published on 15 April 2019
Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease
artículo científico publicado en 2013
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease
artículo científico publicado en 2010
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.
artículo científico publicado en 2014
Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.
artículo científico publicado en 2011
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
artículo científico publicado en 2003
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
artículo científico publicado en 2000
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study
artículo científico publicado en 2004
Measuring longitudinal cognition: Individual tests versus composites
scientific article published on 11 January 2019
Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes
artículo científico publicado en 2009
Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42.
artículo científico publicado en 2010
Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease
artículo científico publicado en 2014
Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract
artículo científico publicado en 2005
Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma
scientific article published on 01 June 2007
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
artículo científico publicado en 2013
Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging
artículo científico publicado en 2017
Mid-life adiposity factors relate to blood-brain barrier integrity in late life
artículo científico publicado en 2007
Mid-life dementia risk scores as a predictor of CSF biomarker response to simvastatin therapy in asymptomatic adults at risk for Alzheimer's disease: The ESPRIT study
artículo científico publicado en 2010
Midlife Stress in Relation to Late-Life Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: A 25-Year Follow-Up Study
scientific article published on 24 August 2018
Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.
artículo científico publicado en 2011
Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences
artículo científico publicado en 2020
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
artículo científico publicado en 2004
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women
scholarly article by Per Johansson et al published 5 August 2011 in Clinical Endocrinology
Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration
artículo científico publicado en 2017
Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics
artículo científico publicado en 1999
Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease.
artículo científico publicado en 2018
Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study
scientific article published on 26 September 2019
Monitoring concussion in a knocked-out boxer by CSF biomarker analysis.
artículo científico publicado en 2014
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
artículo científico publicado en 2017
Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury
artículo científico publicado en 2009
Monitoring of β-amyloid dynamics after human traumatic brain injury
artículo científico publicado en 2013
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
artículo científico publicado en 1989
Monocyte and microglial activation in patients with mood-stabilized bipolar disorder
artículo científico publicado en 2015
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment
artículo científico publicado en 2012
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.
artículo científico publicado en 2007
Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals Aβ Aggregation Dependent Anionic Lipid Accumulations and Metabolism
scientific article published on 19 June 2018
Multiplexing and multivariate analysis in neurodegeneration
artículo científico publicado en 2012
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
artículo científico publicado en 2016
NFL blood levels are moderated by subconcussive impacts in a cohort of college football players
scientific article published on 11 January 2019
NFL is a marker of treatment response in children with SMA treated with nusinersen
artículo científico publicado en 2019
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
artículo científico publicado en 2018
Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury
artículo científico publicado en 2016
Neurochemical aftermath of amateur boxing
artículo científico publicado en 2006
Neurochemical dissection of synaptic pathology in Alzheimer's disease.
artículo científico publicado en 1998
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
artículo científico publicado en 2020
Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation
artículo científico publicado en 2014
Neurochemical measures co-vary with personality traits: forensic psychiatric findings replicated in a general population sample
artículo científico publicado en 2010
Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia
artículo científico publicado en 2018
Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission
artículo científico publicado en 2013
Neuroendocrine Assessment of Serotonergic, Dopaminergic, and Noradrenergic Functions in Alcohol-Dependent Individuals
scientific article published on 28 July 2011
Neurofilament Light in Serum and Cerebrospinal Fluid of Hip Fracture Patients with Delirium
artículo científico publicado en 2018
Neurofilament Protein and Antineurofilament Antibodies Following Traumatic Brain Injury-Reply
artículo científico publicado en 2017
Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke
artículo científico publicado en 2018
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
artículo científico publicado en 2018
Neurofilament light and tau as blood biomarkers for sports-related concussion.
artículo científico publicado en 2018
Neurofilament light chain as a biomarker in neurological disorders
artículo científico publicado en 2019
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy
artículo científico publicado en 2018
Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy
article
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
artículo científico publicado en 2017
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls
artículo científico publicado en 2017
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
scientific article published on 24 April 2020
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
artículo científico publicado en 2016
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice
artículo científico publicado en 2017
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
artículo científico publicado en 2017
Neurofilament light protein in blood predicts regional atrophy in Huntington disease
artículo científico publicado en 2018
Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.
artículo científico publicado en 2018
Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
artículo científico publicado en 2001
Neurofilament protein levels in CSF are increased in dementia.
artículo científico publicado en 1999
Neurofilament relates to white matter microstructure in older adults
scientific article published on 28 June 2018
Neurofilament-Light in Former Athletes: A Potential Biomarker of Neurodegeneration and Progression
scientific article published on 13 April 2020
Neurofilaments as biomarkers in neurological disorders
article by Michael Khalil et al published 31 August 2018 in Nature Reviews Neurology
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
artículo científico publicado en 2016
Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep
scientific article published on 19 December 2019
Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox
scientific article published on 01 November 2015
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease
artículo científico publicado en 2015
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
artículo científico publicado en 2017
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.
artículo científico publicado en 2018
Neurogranin as a predictor of memory and executive function decline in MCI patients
artículo científico publicado en 2018
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
artículo científico publicado en 2010
Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers
artículo científico publicado en 2017
Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
⬇️
artículo científico publicado el 19 de diciembre de 2010
Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy
artículo científico publicado en 2017
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
artículo científico publicado en 2010
Neuroinflammatory markers associate with cognitive decline after major surgery: Findings of an explorative study
artículo científico publicado en 2020
Neurological assessment and its relationship to CSF biomarkers in amateur boxers
artículo científico publicado en 2014
Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?
artículo científico publicado en 1994
Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke
artículo científico publicado en 2014
No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease
artículo científico publicado en 2002
No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
scholarly article by Kaj Blennow et al published 11 August 2000 in Journal of Neural Transmission
No association of LOXL1 gene polymorphisms with Alzheimer's disease.
artículo científico publicado en 2011
No association of VEGF polymorphims with Alzheimer's disease.
artículo científico publicado en 2009
No association of salivary total tau concentration with Alzheimer's disease
scientific article published on 20 June 2018
No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion
scientific article published in PLoS ONE
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.
artículo científico publicado en 2016
No evident neuronal damage after electroconvulsive therapy
scientific article published on 01 October 2000
No neurochemical evidence for brain injury caused by heading in soccer
artículo científico publicado en 2007
No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons
artículo científico publicado en 2011
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization
artículo científico publicado en 2016
Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity
artículo científico publicado en 2014
Non-neurological surgery results in a neurochemical stress response
artículo científico publicado en 2008
Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke
artículo científico publicado en 2001
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report
artículo científico publicado en 2006
Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment
artículo científico publicado en 2011
Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.
artículo científico publicado en 2008
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
artículo científico publicado en 2007
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
artículo científico publicado en 2018
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
artículo científico publicado en 2010
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study
artículo científico publicado en 2017
Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma
artículo científico publicado en 2013
One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis
artículo científico publicado en 2001
Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β.
artículo científico publicado en 2012
Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects
artículo científico publicado en 2016
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's
artículo científico publicado en 2010
P3-071: Mass spectrometric characterization of tau in cerebrospinal fluid
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses
artículo científico publicado en 2010
Parenteral administration of GM1 ganglioside to presenile Alzheimer patients
artículo científico publicado en 1990
Pathogenetic basis of vascular dementia.
artículo científico publicado en 1991
Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease
artículo científico publicado en 2016
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS
artículo científico publicado en 2012
Peptidomic analysis of cartilage and subchondral bone in OA patients
artículo científico publicado en 2019
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study
artículo científico publicado en 2015
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
scientific article published on 24 June 2019
Performance on a pattern separation task by Alzheimer's patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels
artículo científico publicado en 2014
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
artículo científico publicado en 2013
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg
artículo científico publicado en 2020
Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease
artículo científico publicado en 2017
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders
artículo científico publicado en 2010
Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study
artículo científico publicado en 2005
Pinpointing plaques with PIB.
artículo científico publicado en 2006
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
artículo científico publicado en 2016
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study
artículo científico publicado en 2010
Plasma Abeta in Alzheimer's disease--up or down?
artículo científico publicado en 2006
Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.
artículo científico publicado en 2018
Plasma BDNF levels vary in relation to body weight in females
artículo científico publicado en 2012
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
artículo científico publicado en 2015
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
artículo científico publicado en 2020
Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
artículo científico publicado en 2017
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
artículo científico publicado en 2019
Plasma amyloid-β in patients with Tangier disease
artículo científico publicado en 2013
Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
scientific article published on 10 June 2019
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.
artículo científico publicado en 2007
Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort
artículo científico publicado en 2017
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate
artículo científico publicado en 2019
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease
artículo científico publicado en 2017
Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins
artículo científico publicado en 2004
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
scientific article published on 28 November 2019
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease
scientific article published on 28 July 2018
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
scientific article published on 27 September 2019
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease
scientific article published on 10 October 2019
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
artículo científico publicado en 2018
Plasma neurofilament light chain concentration is increased in anorexia nervosa
artículo científico publicado en 2019
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study
artículo científico publicado en 2020
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
artículo científico publicado en 2017
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
artículo científico publicado en 2016
Plasma pyroglutamate-modified amyloid beta differentiates amyloid pathology
artículo científico publicado en 2020
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
scientific article published on 28 June 2019
Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease
artículo científico publicado en 2019
Plasma tau in Alzheimer disease
scientific article published on 30 September 2016
Plasma tau levels in Alzheimer's disease
artículo científico publicado en 2013
Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia
artículo científico publicado en 2011
Plasma β-amyloid in Alzheimer's disease and vascular disease
artículo científico publicado en 2016
Platelet monoamine oxidase B in family history positive and family history negative type 1 alcohol-dependent subjects
artículo científico publicado en 2002
Platelet monoamine oxidase-B activity in type 1 alcohol-dependent subjects in sustained full remission
artículo científico publicado en 2002
Pleiotropy in the Presence of Allelic Heterogeneity: Alternative Genetic Models for the Influence of APOE on Serum LDL, CSF Amyloid-β42, and Dementia
⬇️
artículo científico publicado el 1 de enero de 2010
Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease
artículo científico publicado en 2017
Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults
artículo científico publicado en 2017
Postoperative delirium is associated with increased plasma neurofilament light
artículo científico publicado en 2020
Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability
artículo científico
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
artículo científico publicado en 2016
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
artículo científico publicado en 2016
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
artículo científico publicado en 2017
Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease
artículo científico publicado en 2015
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
artículo científico publicado en 2017
Predicting MCI outcome with clinically available MRI and CSF biomarkers
artículo científico publicado en 2011
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
artículo científico publicado en 2017
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
scientific article published on 24 September 2007
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
artículo científico publicado en 2013
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides
artículo científico publicado en 2008
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment
artículo científico publicado en 2010
Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
artículo científico publicado en 2007
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
artículo científico publicado en 2020
Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project
artículo científico publicado en 1999
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
artículo científico publicado en 2009
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
artículo científico publicado en 2015
Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.
artículo científico publicado en 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.
artículo científico publicado en 2018
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
scientific article published on 08 May 2019
Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry
artículo científico publicado en 1998
Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
artículo científico publicado en 2001
Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers
artículo científico publicado en 2012
Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations
artículo científico publicado en 2011
Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies
scientific article published on 03 October 2019
Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease
artículo científico publicado en 2015
Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio
artículo científico publicado en 1993
Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.
artículo científico publicado en 1993
Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production
artículo científico publicado en 1993
Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats
artículo científico publicado en 2007
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
artículo científico publicado en 2002
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry
artículo científico publicado en 2001
Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
artículo científico publicado en 2010
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
artículo científico publicado en 2017
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
⬇️
artículo científico publicado el 21 de octubre de 2003
Proteomics profiling of single organs from individual adult zebrafish
artículo científico publicado en 2010
Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases
artículo científico publicado en 2009
Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia.
artículo científico publicado en 2010
Publisher Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
scholarly article by Kina Höglund et al published 19 November 2018 in Translational Psychiatry
Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics
artículo científico publicado en 2000
Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease
artículo científico publicado en 2012
Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
artículo científico publicado en 2019
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.
artículo científico publicado en 2011
Quality Assessment of 25(OH)D, Insulin, Total Cholesterol, Triglycerides, and Potassium in 40-Year-Old Frozen Serum
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
artículo científico publicado en 2000
Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases
Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid
⬇️
artículo científico publicado el 11 de marzo de 1991
Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels
artículo científico publicado en 2005
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum
artículo científico publicado en 2013
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype
artículo científico publicado en 2009
Rarity of the Alzheimer disease-protective APP A673T variant in the United States
artículo científico publicado en 2015
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
artículo científico publicado en 2016
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
artículo científico publicado en 2016
Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head
artículo científico publicado en 2003
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
artículo científico publicado en 2017
Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.
artículo científico publicado en 2016
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
artículo científico publicado en 2009
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
artículo científico publicado en 2017
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
artículo científico publicado en 2012
Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease
artículo científico publicado en 2001
Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
artículo científico publicado en 2013
Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
artículo científico publicado en 2009
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
artículo científico publicado en 2018
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study
scientific article published on 18 April 2019
Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia
artículo científico publicado en 1999
Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia
scientific article published on 01 December 1999
Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.
artículo científico publicado en 2000
Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia
artículo científico publicado en 2002
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
artículo científico publicado en 2016
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
artículo científico
Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.
artículo científico publicado en 1994
Relationship between CSF biomarkers and language fluency in asymptomatic middle-aged adults at increased risk for Alzheimer's disease: The ESPRIT study
artículo científico publicado en 2010
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus
artículo científico publicado en 2009
Relationship between mental impairment and HPA axis activity in dementia disorders.
artículo científico publicado en 1994
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease
scientific article published on 01 April 2019
Removal of sodium dodecyl sulfate from protein samples prior to matrix-assisted laser desorption/ionization mass spectrometry
artículo científico publicado en 1999
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
scientific article published on 13 December 2019
Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative
artículo científico publicado en 2014
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
artículo científico publicado en 2019
Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study
artículo científico publicado en 2011
Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation
artículo científico publicado en 2001
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.
artículo científico publicado en 2015
S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment
artículo científico publicado en 2010
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies
artículo científico publicado en 2018
SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration
artículo científico publicado en 2011
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
artículo científico publicado en 2014
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease
artículo científico publicado en 2012
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
artículo científico publicado en 2008
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
artículo científico publicado en 2012
Salivary Biomarkers for Alzheimer's Disease and Related Disorders
scientific article published on 12 December 2019
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
artículo científico publicado en 2017
Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease
artículo científico publicado en 2011
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
artículo científico publicado en 2019
Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production
artículo científico publicado en 2012
Semagacestat's fall: where next for AD therapies?
artículo científico publicado en 2013
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.
artículo científico publicado en 1999
Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain
artículo científico publicado en 2005
Sequence variation in SORL1 and dementia risk in Swedes
artículo científico publicado en 2009
Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.
artículo científico publicado en 2004
Serotonergic, noradrenergic, and dopaminergic measures in suicide brains
artículo científico publicado en 1997
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load
artículo científico publicado en 2020
Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke
scientific article published on 28 May 2019
Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest
artículo científico publicado en 2019
Serum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries
scientific article published on 23 April 2019
Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study
artículo científico publicado en 2016
Serum Neurofilament Light in American Football Athletes Over the Course of a Season
artículo científico publicado en 2015
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
artículo científico publicado en 2019
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
artículo científico
Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms
artículo científico publicado en 2014
Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players
artículo científico publicado en 2015
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
articulo cientifico
Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability.
artículo científico publicado en 2017
Serum erythropoietin and outcome after ischaemic stroke: a prospective study
artículo científico publicado en 2016
Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage
artículo científico publicado en 2007
Serum levels of LIGHT in MS
article by Clas Malmeström et al published 4 October 2012 in Multiple Sclerosis Journal
Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury
scientific article published on 14 January 2008
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
artículo científico publicado en 2017
Serum neurofilament light chain in progressive supranuclear palsy
scientific article published on 12 June 2018
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
artículo científico publicado en 2016
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
artículo científico publicado en 2017
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
artículo científico publicado en 2016
Serum tau and neurological outcome in cardiac arrest.
artículo científico publicado en 2017
Serum tau concentration after diving - an observational pilot study
scientific article published on 01 June 2019
Serum visinin-like protein-1 in concussed professional ice hockey players
artículo científico publicado en 2015
Sex difference in CHI3L1 expression levels in human brain aging and in Alzheimer's disease
scientific article published on 24 June 2019
Sex differences in the genetic predictors of Alzheimer's pathology
scientific article published on 01 September 2019
Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau
scientific article published on 01 August 2018
Sex-specific genetic predictors of Alzheimer's disease biomarkers
artículo científico publicado en 2018
Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice using Multimodal MALDI Imaging Mass Spectrometry.
artículo científico publicado en 2018
Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?
artículo científico publicado en 2010
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease
artículo científico publicado el 1 de enero de 1992
Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
artículo científico publicado en 2004
Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid
artículo científico publicado en 2011
Sleep Deprivation and CSF Biomarkers for Alzheimer Disease
artículo científico publicado en 2018
Sleep deprivation and plasma biomarkers for Alzheimer's disease
scientific article published on 12 February 2019
Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau
artículo científico publicado en 2019
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years
article
Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4.
artículo científico publicado en 2018
Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment
artículo científico publicado en 2010
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression
artículo científico publicado en 2019
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease
artículo científico publicado en 2013
Spatial Chemometrics and Comprehensive Chemical Imaging based Molecular Histopathology Delineates Anatomical Heterogeneity at Single Pixel Resolution
Specific Triazine Herbicides Induce Amyloid-β42 Production
artículo científico publicado en 2016
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
artículo científico publicado en 2000
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative
artículo científico publicado en 2011
State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression
artículo científico publicado en 2016
Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease
artículo científico publicado en 2005
Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia
artículo científico publicado en 1996
Steroid-responsive encephalitis in Covid-19 disease
scientific article published on 17 May 2020
Steroid-responsive encephalitis in Covid-19 disease
artículo científico publicado en 2020
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
artículo científico publicado en 2017
Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains
artículo científico publicado en 2005
Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins
artículo científico publicado en 2002
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.
artículo científico publicado en 2009
Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.
artículo científico publicado en 2005
Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis
artículo científico publicado en 2017
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia
artículo científico publicado el 1 de febrero de 1992
Sustained release of neuron-specific enolase to serum in amateur boxers
artículo científico publicado en 2009
Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia
scientific article published on 01 January 2000
Synaptic degeneration in thalamus in schizophrenia
artículo científico publicado en 1996
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
artículo científico publicado en 1996
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
artículo científico publicado en 2018
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease
artículo científico publicado en 2009
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
scientific article published on 20 February 2019
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
scientific article published on 06 January 2020
Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?
artículo científico publicado en 1996
TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease
artículo científico publicado en 2005
TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.
artículo científico publicado en 2000
TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly
artículo científico publicado en 2011
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype
artículo científico publicado en 2001
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.
artículo científico publicado en 2014
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device
artículo científico publicado en 2016
Targeted proteomics in Alzheimer's disease: focus on amyloid-beta
artículo científico publicado en 2008
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
artículo científico publicado en 2016
Targeting synaptic pathology with a novel affinity mass spectrometry approach
artículo científico publicado en 2014
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.
artículo científico publicado en 2001
Tau as a molecular biomarker in cerebrospinal fluid and plasma
article published in 2014
Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification
artículo científico publicado en 2007
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
artículo científico publicado en 2017
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
artículo científico publicado en 2017
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
artículo científico publicado en 1995
Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study
artículo científico publicado en 2012
Tau, s-100 calcium-binding protein B, and neuron-specific enolase as biomarkers of concussion-reply
artículo científico publicado en 2014
Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage
artículo científico publicado en 2020
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid
artículo científico publicado en 2015
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.
artículo científico publicado en 2012
The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data
The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort
artículo científico publicado en 2016
The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.
artículo científico publicado en 2008
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
artículo científico publicado en 2011
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
artículo científico publicado en 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases
artículo científico publicado en 2015
The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease
artículo científico publicado en 2016
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up
artículo científico publicado en 2015
The Influence of Metabolic Syndrome on Simvastatin Therapy In Asymptomatic Adults at Risk for Alzheimer's Disease: The ESPRIT Study
artículo científico publicado en 2010
The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis
artículo científico publicado en 2011
The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association
scientific article published on 11 September 2007
The Past and the Future of Alzheimer's Disease Fluid Biomarkers.
artículo científico publicado en 2018
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations
artículo científico publicado en 2014
The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease
artículo científico publicado en 2014
The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain
scholarly article by Yohanna Eriksson et al published 10 July 2018 in Cell Death and Disease
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease
artículo científico publicado en 1996
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
artículo científico publicado en 1997
The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee
artículo científico publicado en 2004
The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase
artículo científico publicado en 2009
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease
artículo científico publicado en 2013
The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism
artículo científico publicado en 2013
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients
scientific article published on 14 August 2008
The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.
artículo científico publicado en 2006
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?
artículo científico publicado en 2014
The clinical diagnosis of vascular dementia
artículo científico publicado en 1994
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease
artículo científico publicado en 2020
The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative
artículo científico publicado en 2014
The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply
artículo científico publicado en 2016
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
⬇️
artículo científico publicado el 1 de enero de 2011
The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution
artículo científico publicado en 1996
The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth
artículo científico publicado en 2015
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease
artículo científico publicado en 2005
The effects of different familial Alzheimer's disease mutations on APP processing in vivo
artículo científico publicado en 2017
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease
artículo científico publicado en 2007
The future of blood-based biomarkers for Alzheimer's disease
artículo científico publicado en 2013
The glial marker YKL-40 is decreased in synucleinopathies
artículo científico publicado en 2013
The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia
artículo científico publicado en 1999
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease
scholarly article by Nicholas M Vogt et al published 22 December 2018 in Alzheimers Research & Therapy
The immune response of the human brain to abdominal surgery
artículo científico publicado en 2017
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
scientific article published on 23 June 2018
The impact of social networks and APOE ε4 on dementia among older adults: tests of possible interactions
artículo científico publicado en 2018
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology
artículo científico publicado en 2017
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease
scientific article published on 22 September 2018
The link between cholesterol and Alzheimer's disease
artículo científico publicado en 2005
The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study
artículo científico publicado en 2004
The neurochemistry of vascular dementia.
artículo científico publicado en 1994
The neuropathology and neurobiology of traumatic brain injury
artículo científico
The new cholesterol controversy - a little bit of history repeating?
artículo científico publicado en 2006
The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease
artículo científico publicado en 2018
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid
scientific article published on 23 November 2019
The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events
artículo científico publicado en 2015
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium
artículo científico publicado en 2008
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
artículo científico publicado en 2016
The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease
artículo científico publicado en 2018
The recency ratio is associated with reduced CSF glutamate in late-life depression
artículo científico publicado en 2017
The recency ratio is related to CSF amyloid beta 1-42 levels in MCI-AD
scientific article published on 10 December 2018
The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals
artículo científico publicado en 2015
The relationship between cerebrospinal fluid biomarkers and depression in elderly women
artículo científico publicado en 2007
The role of clusterin in amyloid-β-associated neurodegeneration
artículo científico publicado en 2014
The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.
artículo científico publicado en 1999
The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.
artículo científico publicado en 2009
The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains
artículo científico publicado en 1999
The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small
artículo científico publicado en 2006
The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease
scientific journal article
The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease
artículo científico publicado en 2005
The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion
artículo científico publicado en 2002
The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C
⬇️
artículo científico publicado el 1 de mayo de 2003
The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials
artículo científico
There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk
artículo científico publicado en 2005
Thrombocytopenia in early alcohol withdrawal is associated with development of delirium tremens or seizures
artículo científico publicado en 2009
Total and phosphorylated tau protein as biological markers of Alzheimer's disease
artículo científico publicado en 2009
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair
artículo científico publicado en 2015
Towards compendia of negative genetic association studies: an example for Alzheimer disease
artículo científico publicado en 2005
Trabalho de consenso de força-tarefa da WFSBP sobre marcadores biológicos das demências: contribuição da análise do LCR e do sangue para o diagnóstico precoce e diferencial das demências
Transcobalamin polymorphism and homocysteine
artículo científico publicado en 2001
Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease.
artículo científico publicado en 2004
Transient increase in CSF GAP-43 concentration after ischemic stroke
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
artículo científico publicado en 2001
Transient inflammation in neurogenic regions after irradiation of the developing brain
Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
artículo científico publicado en 2018
Traumatic brain injuries.
artículo científico publicado en 2016
Treatment of Alzheimer's disease with clioquinol
artículo científico publicado en 2001
Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein
artículo científico publicado en 2003
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP
Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid
artículo científico publicado en 2019
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
artículo científico publicado en 2014
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
artículo científico publicado en 2017
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease
artículo científico publicado en 2010
Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts
⬇️
artículo científico publicado en 2011
Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.
artículo científico publicado en 1994
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease
artículo científico publicado en 2019
Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets
artículo científico publicado en 2003
Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
artículo científico publicado en 2015
Update on biomarkers for amyloid pathology in Alzheimer's disease
artículo científico publicado en 2018
Update on fluid biomarkers for concussion
scientific article published on 18 February 2016
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
artículo científico publicado en 2010
Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
artículo científico publicado en 2016
Use of CSF biomarkers in Alzheimer's disease clinical trials.
artículo científico publicado en 2009
Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
artículo científico publicado en 2010
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
artículo científico publicado en 2006
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
artículo científico publicado en 2009
Validation of a new assay for α-synuclein detection in cerebrospinal fluid
artículo científico publicado en 2016
Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients
artículo científico publicado en 2004
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
artículo científico publicado en 2015
Validity and Normative Data for the Biber Figure Learning Test: A Visual Supraspan Memory Measure
scientific article published on 01 May 2018
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
artículo científico publicado en 2004
Variability in the kinesin light chain 1 gene may influence risk of age-related cataract.
scientific article published on 27 June 2007
Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease
artículo científico
Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus
artículo científico publicado en 2007
Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men
artículo científico publicado el 1 de abril de 1992
Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment
artículo científico publicado en 2003
Vitamin D supplementation and neurofilament light chain in multiple sclerosis
artículo científico publicado en 2018
White matter changes in familial Alzheimer's disease
artículo científico publicado en 2015
White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia--diagnostic and pathogenetic aspects
artículo científico publicado en 1989
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.
artículo científico publicado en 2018
White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors
artículo científico publicado en 1991
Withdrawn: Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer's disease
artículo científico publicado en 2016
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis
artículo científico publicado en 2016
Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid
artículo científico publicado en 2009
[Alzheimer's disease - the most common cause of dementia]
scientific article published on 09 March 2020
[Automated cerebrospinal fluid cell count. A valuable contribution to diagnostics of brain diseases]
artículo científico publicado en 2011
[Biomarkers in cerebrospinal fluid and blood in memory complaints].
artículo científico publicado en 2009
[CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice]
artículo científico publicado en 2001
[Exercise and weight loss does not reduce cardiovascular risk in type 2 diabetes]
[Guidelines for brain concussion in sports--how are they to be applied in boxing?].
artículo científico publicado en 2007
[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis]
artículo científico publicado en 2000
[New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].
artículo científico publicado en 2005
[The concept of dementia--does it enlighten or confuse?]
artículo científico publicado en 1993
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
artículo científico publicado en 2010
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
artículo científico publicado en 2016
β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
artículo científico publicado en 2014